Pharma Market Access and Pricing

Who should attend?

• Pricing, Market Access Professionals who want to learn about regional markets.
• Regulatory professionals who want to learn about commercial issues.
• Strategic planners who want to know where they might go next
• Those who want insight into the way that markets influence each other
• Anyone who wants to understand global pricing issues

Graduation in any discipline.

1. Attend the course 24×7 by login to your dashboard. Therefore, one can attend lectures, simulation, self assessment tests and final certification examination online at own convenience.
2. You will also be eligible to receive the course study modules, which you can download by login to your course page.

Course Features

This online course utilizes 24×7 interactive learning tools to guide each participant through the steps of market access, pricing, forecasting and reimbursement. Moreover this market access training challenges participants to apply what they have learned through the use of interactive exercises, reflection questions, expert live chat and a final assessment at the end of the course.

Important Learning Features: 

• The course provided comprehensive advanced understanding on global and national pricing, market access, pricing, forecasting.
• Advance practical training in health economics and evidence based pricing concepts.
• Advance training on market assessment to determine pricing models.
• Detailed training on forecasting models and techniques with practical case studies.
• Training on value dossier preparation.
• Health Economics.
• Health Technology Assessments.
• Patient Advocacy.

Related Courses

At Royed Training, we have 1 year PG Cortication in Pharma Market Access.

Followings are the few of the similar courses, you may be interested in

• Pharma Global Management >> Click here
• Biopharma Global Business Course >> Click here
• Drug Regulatory Affairs Course >> Click here
• Online Training on CE certification >> Click here
• Medical devices regulatory affairs >> Click here
• Drug, Biologic and Medical Devices Regulatory Affairs Course >> Click here
• USFDA Pharmaceutical and Biopharmaceutical Regulatory Affairs >> Click here

What is Market Access?

Pharmaceutical market access refers to the process by which pharmaceutical companies gain approval, reimbursement, and availability for their products in healthcare systems. Hence it allows the patients to access and benefit from those medications. Above all, pharma market access training involves a combination of regulatory, economic, and clinical considerations to ensure that pharmaceutical products are accessible to patients who need them.

Focus Area for Market Access Professionals

Here are the focus area where market access professionals focuses on day to day basis.

Regulatory Approval

Before a pharmaceutical product can be marketed, it must undergo a rigorous approval process by regulatory authorities, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe. These agencies evaluate the safety, efficacy, and quality of the product based on preclinical and clinical trial data provided by the manufacturer. That is the reason, Royed Market Access training provides hands-on knowledge on regulatory approval process in EU and US market.

Reimbursement and Pricing

Once a product receives regulatory approval, the next step is to secure reimbursement from public and private payers, such as government healthcare programs, insurance companies, or health maintenance organizations. Hence, this involves demonstrating the clinical and economic value of the medication compared to existing treatments. Therefore, pharmaceutical companies often engage in price negotiations with payers to determine an appropriate price that balances affordability and profitability. In fact our course provides key insight on pricing and reimbursement with case studies.

Health Economics (HE) and Health Technology Assessment (HTA)

HE and HTA agencies evaluate the clinical effectiveness, cost-effectiveness, and budget impact of pharmaceutical products. These assessments help inform reimbursement decisions by payers, as they consider factors such as clinical outcomes, patient population, cost-effectiveness, and budget impact on the healthcare system. At Royed Pharma Market Access course, advanced training on health economics and health Technology Assessment process. Hence, one can easily plan, evaluate and pick best possible therapeutic alternatives which provides best value.

Market Access Strategy

This is the core focus area for the market professionals. Pharmaceutical companies develop market access strategies to navigate the complex landscape of regulations, payer requirements, and pricing negotiations. Therefore it involves identifying target markets, understanding the local healthcare systems, building relationships with key stakeholders, and tailoring evidence and value messages to demonstrate the benefits of their products. Royed Pharma Market Access course provides all possible insight on market access strategic planning process.

Real-World Evidence

Real World Evidence is the buzz-word today in Pharmaceutical Industry. Increasingly, payers and regulatory authorities are placing importance on real-world evidence (RWE) to support market access decisions. RWE refers to data collected from real-world settings, such as observational studies and patient registries, to assess the long-term safety, effectiveness, and value of pharmaceutical products beyond clinical trials. In 2023, Royed Market Access course is now updated with real world data, real world evidence.

Patient Access Programs

Pharmaceutical companies may develop patient access programs to help eligible patients gain access to their medications. These programs may offer financial assistance, patient support services, or other initiatives to help overcome barriers to access, particularly for patients facing financial hardship or with limited insurance coverage. Hence, Patient Access Program is the key learning area for the Market Access Professionals.